The page is the record's research on the issuer — no analyst, no rating, no view.

4BASEBIO PLC (4BB) — research page

UK · uk-cm-kg/AIM/4BB · as of 2026-11-06

Identity and listing

The issuer is 4BASEBIO PLC, listed on AIM under ticker 4BB, with ISIN GB00BMCLYF79 and LEI 213800E2DX9EAIUNCB30. Its security type is Corporate, its segment is ASQ1, its sector is Pharmaceuticals and Biotechnology [201030], and its jurisdiction is England and Wales (Companies House jurisdiction field). The record holds its status as listed, not halted.

fieldvaluesource · read date
name4BASEBIO PLCsource · 2026-11-06
exchangeAIMsource · 2026-11-06
ticker4BBsource · 2026-11-06
ISINGB00BMCLYF79source · 2026-11-06
LEI213800E2DX9EAIUNCB30source · 2026-11-09
security typeCorporatesource · 2026-11-06
segmentASQ1source · 2026-11-06
sectorPharmaceuticals and Biotechnology [201030]source · 2026-11-06
jurisdictionEngland and Wales (Companies House jurisdiction field)source · 2026-11-06
statuslisted, not haltedsource · 2026-11-09

The disclosure read

The record holds 41 filings across 28 filing days in the window 2025-11-06 to 2026-11-06. The median gap between filing days is 6 days. The latest filing is dated 2026-11-06 and is of type agm_record_date, which is 0 days before the record date of 2026-11-06. The exchange median is 7.0 days of cadence and 4 days of latency across 594 issuers, with a median of 33.5 filings. The sector median is 6.0 days of cadence and 4.0 days of latency across 51 issuers, with a median of 42 filings. The issuer's 41 filings are above the exchange median and below the sector median of 42.

filingsmedian gap between filing daysdays from latest filing to as-of
this issuer4160
exchange median: AIM (594 issuers)33.574
sector median: Pharmaceuticals and Biotechnology [201030] (51 issuers)4264
datetypecategoryfiling
2026-11-06agm_record_dateResult of General Meeting
2026-10-21regulatory_announcementResult of Retail Offer
2026-10-20regulatory_announcementPosting of Circular and Notice of General Mee...
2026-10-15regulatory_announcementResults of Capital Raise
2026-10-15regulatory_announcementProposed Retail Offer

window 2025-11-06 to 2026-11-06 · the node's disclosure lines, as get_filings serves them

Auditor

The auditor of record is Crowe U.K. LLP. Its location is not on the record. Auditor changes are not on the record, as the market's register has no lifecycle type map yet.

Events and halts

Listing, delisting, name change, domicile change and segment move are not on the record, as the market's register has no lifecycle type map yet. The halt flag is listed, not halted.

Orderability

For elective professional client, the outcome is signal ACM-200, determinable. For eligible counterparty, the outcome is signal ACM-200, determinable. The rule version is acm-68000/uk/product-governance-fca-prod-sourcebook/r1, with the chapter as of 2026-11-04.

client categoryoutcome
elective professional clientACM-200
eligible counterpartyACM-200

rule acm-68000/uk/product-governance-fca-prod-sourcebook/r1 · chapter as of 2026-11-04 · the full outcome: get_orderability

Coverage

The issuer's own investor-relations page names 2 research houses: Cavendish and Singer Capital Markets.

research houseanalystsource · read date
CavendishAdam McCarterissuer page · 2026-11-12
Singer Capital MarketsKarl Keeganissuer page · 2026-11-12

Open research

No openly published research notes were found on the record.

Licensed

Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.

licensorentitlementtitledatesource
none loaded

As-of depth

No issuer years are sealed. The market's vintage is not sealed, and no earliest sealed date is held. The live record began on 2026-09-11. The store holds 2021 through 2026 sealed, but these years are not served as of a date; the as-of door answers not_sealed.

Sources

11 source pages are named on this page; every value above carries its own source page and read date in the numbers.

10.1
https://www.londonstockexchange.com/live-markets/market-data-dashboard/price-explorer (identity.exchange)
10.2
https://api.londonstockexchange.com/api/gw/lse/instruments/alldata/4BB (identity.isin)
10.3
https://find-and-update.company-information.service.gov.uk/company/13519889 (identity.jurisdiction)
10.4
https://mapping.gleif.org/api/v2/isin-lei/latest/download (identity.lei)
10.5
https://www.londonstockexchange.com/stock/4BB/4basebio-plc/company-page (identity.sector)
10.6
https://mcp.uk-cm-kg.ai/events/AIM/4BB (the disclosure lines)
10.7
https://marketsecurities.fca.org.uk/officiallist (the halt flag)
10.8
https://static1.squarespace.com/static/6800cf81ffa29d1745938e9e/t/683f5a7366ea7d1a77db175c/1748982388997/Annual-Report-2023.pdf (the auditor)
10.9
https://mcp.uk-cm-kg.ai/book/aio.json (the orderability chapter)
10.10
https://www.4basebio.com/analyst-coverage (coverage)
10.11
https://mcp.uk-cm-kg.ai/record/AIM/4BB (the record)

Read it by agent

The same page, signed and receipted: get_research at https://mcp.getresearch.ai/mcp with {"isin":"GB00BMCLYF79"}. Twins: .md · .json. Written: Claude through the platform account, Haiku class; one pass; checked against the numbers. Page hash sha256:318a5699666a2906.